3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
25
Prostatic Neoplasms
23
Carcinoma, Non-Small-Cell Lung
15
Multiple Myeloma
14
Sarcoma
12
Leukemia, Myeloid, Acute
12
Breast Neoplasms
12
Lymphoma, Non-Hodgkin
10
Glioma
10
Wilms Tumor
9
Colorectal Neoplasms
9
Carcinoma, Hepatocellular
9
Rectal Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Ovarian Neoplasms
8
Osteosarcoma
8
Neuroblastoma
8
Neoplasm Metastasis
8
Myelodysplastic Syndromes
8
Rhabdomyosarcoma
7
Rhabdoid Tumor
7
Pancreatic Neoplasms
7
Medulloblastoma
7
Hepatoblastoma
7
Neuroectodermal Tumors, Primitive, Peripheral
6
Mouth Neoplasms
6
Melanoma
6
Lymphoma
6
Histiocytosis, Langerhans-Cell
6
Head and Neck Neoplasms
6
Interventions
Cyclophosphamide
10
Doxorubicin
9
Vincristine
7
Etoposide
7
Ifosfamide
6
Filgrastim
5
Radiotherapy
4
fludarabine phosphate
3
Topotecan
3
Thiotepa
3
Temozolomide
3
Peripheral Blood Stem Cell Transplantation
3
Melphalan
3
Irinotecan
3
Cisplatin
3
Carboplatin
3
Brachytherapy
3
seclidemstat
2
Tacrolimus
2
PM 01183
2
Neoadjuvant Therapy
2
Injections
2
Hyperthermic Intraperitoneal Chemotherapy
2
Granulocyte Colony-Stimulating Factor
2
Epirubicin
2
Dactinomycin
2
Cytoreduction Surgical Procedures
2
Cyclosporine
2
Chemotherapy, Adjuvant
2
thymoglobulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Desmoplastic Small Round Cell Tumor
×
X-Rays
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled